Showing results (101-110 of 135) with videos related to
Sort By:
Pageof 14
Therapeutic Advances in Medical Oncology|August 1, 2020
Atezolizumab in a CoHort of pretreated, advanced, non-small cell lung cancer patients with rare HistologiCal SubtypEs (CHANCE trial)Francesco Gelsomino, Giuseppe Lamberti, Marcello Tiseo, et al.Vaccines|May 27, 2023
Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma InfectionNadia Marascio, Maria Teresa Loria, Grazia Pavia, et al.Future Oncology (London, England)|January 24, 2022
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationaleElisa Andrini, Giuseppe Lamberti, Francesca Mazzoni, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 26, 2025
Gene Copy Deletion of STK11, KEAP1, and SMARCA4: Clinicopathologic Features and Association With the Outcomes of Immunotherapy With or Without Chemotherapy in Nonsquamous NSCLCMalini M Gandhi, Arielle Elkrief, Catherine Gutierrez Moore, et al.BMC Infectious Diseases|September 20, 2014
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antiviralsAlessio Strazzulla, Chiara Costa, Vincenzo Pisani, et al.Journal of Clinical Medicine|October 14, 2022
Angioside: The role of Angiogenesis and Hypoxia in Lung Neuroendocrine Tumours According to Primary Tumour Location in Left or Right ParenchymaAnna La Salvia, Raffaella Carletti, Monica Verrico, et al.Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine TumorGiuseppe Lamberti, Antongiulio Faggiano, Nicole Brighi, et al.Infectious Agents and Cancer|August 4, 2017
Six years genotype distribution of Human Papillomavirus in Calabria Region, Southern Italy: a retrospective studyLuisa Galati, Cinzia Peronace, Maria Teresa Fiorillo, et al.Future Oncology (London, England)|June 26, 2018
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Enrico Franceschi, Antonella Mura, Dario De Biase, et al.Pageof 14